Nicholas Company’s Sanofi SNY Stock Holding History

Nicholas Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Sell	146,520 -1,352,470	-90%	-$60.4M	0.11%	151
2026 Q1	$72.2M	Sell	1,498,990 -1,265	-0.1%	-$59K	1.42%	16
2025 Q4	$72.7M	Sell	1,500,255 -110	-0%	-$5.45K	1.27%	19
2025 Q3	$70.8M	Buy	1,500,365 +103,100	+7%	+$4.98M	1.2%	21
2025 Q2	$67.5M	Buy	1,397,265 +127,210	+10%	+$6.5M	1.13%	29
2025 Q1	$70.4M	Buy	1,270,055 +180	+0%	+$9.74K	1.22%	21
2024 Q4	$61.2M	Buy	1,269,875 +50	+0%	+$2.54K	0.99%	34
2024 Q3	$73.2M	Buy	1,269,825 +44,335	+4%	+$2.39M	1.19%	26
2024 Q2	$59.5M	Buy	1,225,490 +91,920	+8%	+$4.43M	0.99%	36
2024 Q1	$55.1M	Buy	+1,133,570	New	+$55.4M	0.91%	42

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nicholas Company's SNY Position: Q2 2026 in Review

Nicholas Company reduced its Sanofi (SNY) stake by 90% in Q2 2026, selling an estimated $60.4M and leaving 146,520 shares worth $6.25M. The position accounts for 0.11% of the portfolio, ranked #151.

Nicholas Company first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $73.2M in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Nicholas Company held 146,520 shares of Sanofi worth $6.25M as of Q2 2026.
Nicholas Company sold 1,352,470 Sanofi shares in Q2 2026, an estimated $60.4M.
Sanofi made up 0.11% of Nicholas Company's portfolio in Q2 2026, its #151 holding.
Nicholas Company first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
Nicholas Company's Sanofi position peaked at $73.2M in Q3 2024.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.